Effect of Melanotan-II on Brain Fos Immunoreactivity and Oxytocin Neuronal Activity and Secretion in Rats.
Effect of Melanotan-II on Brain Fos Immunoreactivity and Oxytocin Neuronal Activity and Secretion in Rats.
复制标题
Melanotan-II 对大鼠脑 Fos 免疫反应性和催产素神经元活性和分泌的影响。
DOI:
10.1111/jne.12454
复制
发表时间:
2017
影响因子:
3.2
通讯作者:
Paiva L
中科院分区:
文献类型:
--
作者:
Paiva L
Melanocortins stimulate the central oxytocin systems that are involved in regulating social behaviours. Alterations in central oxytocin have been linked to neurological disorders such as autism, and melanocortins have been proposed for therapeutic treatment. In the present study, we investigated how systemic administration of melanotan‐II (MT‐II), a melanocortin agonist, affects oxytocin neuronal activity and secretion in rats. The results obtained show thati.v., but not intranasal, administration of MT‐II markedly induced Fos expression in magnocellular neurones of the supraoptic (SON) and paraventricular nuclei (PVN) of the hypothalamus, and this response was attenuated by priori.c.v.administration of the melanocortin antagonist, SHU‐9119. Electrophysiological recordings from identified magnocellular neurones of the SON showed thati.v.administration of MT‐II increased the firing rate in oxytocin neurones but did not trigger somatodendritic oxytocin release within the SON as measured by microdialysis. Our data suggest that, afteri.v., but not intranasal, administration of MT‐II, the activity of magnocellular neurones of the SON is increased. Because previous studies showed that SON oxytocin neurones are inhibited in response to direct application of melanocortin agonists, the actions ofi.v.MT‐II are likely to be mediated at least partly indirectly, possibly by activation of inputs from the caudal brainstem, where MT‐II also increased Fos expression.